Jove
Visualize
Contact Us

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ongoing challenge of slowing ageing through drug discovery.

Expert opinion on drug discovery·2025
Same author

Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project.

GeroScience·2025
Same author

Symposia Report of The Annual Biological Sciences Section Meeting of the Gerontological Society of America 2023, Tampa, Florida.

The journals of gerontology. Series A, Biological sciences and medical sciences·2025
Same author

Optimal data acquisition in tomography.

Journal of the Optical Society of America. A, Optics, image science, and vision·2023
Same author

Neurobiology of Aging: New Insights From Across the Research Spectrum.

The journals of gerontology. Series A, Biological sciences and medical sciences·2023
Same author

GSA Journal Commitment to Inclusion, Equity, and Diversity: Editors Announce New Guidance.

Innovation in aging·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 23, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

PGC-1alpha in aging and anti-aging interventions.

Rozalyn Anderson1, Tomas Prolla

  • 1Wisconsin National Primate Research Center, Madison, WI 53715, USA. rmanderson5@wisc.edu

Biochimica Et Biophysica Acta
|April 18, 2009
PubMed
Summary

Mitochondrial dysfunction is linked to aging and metabolic diseases. The study explores how PGC-1alpha, a key regulator, influences mitochondrial health during aging.

Area of Science:

  • Gerontology
  • Mitochondrial Biology
  • Metabolic Regulation

Background:

  • Mitochondrial dysfunction is a hallmark of aging and metabolic diseases.
  • Caloric restriction, an aging-delaying intervention, involves altered mitochondrial function.
  • PGC-1alpha is a crucial regulator of mitochondrial energy metabolism and biogenesis.

Purpose of the Study:

  • To investigate the role of PGC-1alpha in aging-related mitochondrial decline.
  • To describe cellular and tissue-specific mechanisms regulating PGC-1alpha.
  • To illustrate how PGC-1alpha pathways are involved in the aging process.

Main Methods:

  • Review of cellular and tissue-specific mechanisms of PGC-1alpha regulation.
  • Analysis of PGC-1alpha's role in mitochondrial energy metabolism and biogenesis.

Related Experiment Videos

Last Updated: Jun 23, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

  • Integration of PGC-1alpha pathways into the context of aging.
  • Main Results:

    • Deregulation of mitochondrial function is common in aging.
    • PGC-1alpha is a critical regulator of mitochondrial biogenesis and energy metabolism.
    • PGC-1alpha pathways are implicated in the aging process and age-associated diseases.

    Conclusions:

    • PGC-1alpha is a key target for addressing age-related mitochondrial decline.
    • Understanding PGC-1alpha regulation offers insights into aging and metabolic disease.
    • Targeting PGC-1alpha may hold therapeutic potential for age-related conditions.